Incidence and characterization of secondary CNS lymphoma in 1972 patients with DLBCL: a Danish nationwide cohort study

Authors: Tolley, Elisabeth Reuben ^{1, 2}, Nielsen, Torsten Holm ^{1, 3, 4}, Hersby, Ditte Stampe ¹, Østergaard, Simon ^{3, 5}, Rasmussen, Malin ⁶, Clausen, Michael Roost ⁷, Al-Mashhadi, Ahmed Ludvigsen ⁸, Egeberg, Karina Moeslund ⁹, Haunstrup, Laura Mors ¹⁰, Brieghel, Christian ¹, Niemann, Carsten Utoft ^{1, 2}, El-Galaly, Tarec Christoffer ^{6, 10}, Pedersen, Lars Møller ^{2, 3, ∗}

Source: In Blood Advances 25 February 2025 9(4):893-905

The impact of trial inclusion criteria on outcomes in DLBCL patients treated with R-CHOP in the first line: a Danish nationwide study.

Authors: Simonsen, Mikkel Runason¹ (AUTHOR), Haunstrup, Laura Mors¹ (AUTHOR) lamo@rn.dk, Severinsen, Freja Tang¹ (AUTHOR), Jensen, Rasmus Kuhr¹ (AUTHOR), Brown, Peter de Nully² (AUTHOR), Maurer, Matthew J.³ (AUTHOR), Khurana, Arushi⁴ (AUTHOR), Jensen, Paw¹ (AUTHOR), Jørgensen, Judit Mészáros⁵ (AUTHOR), Stauffer Larsen, Thomas⁶ (AUTHOR), Clausen, Michael Roost⁷ (AUTHOR), Poulsen, Christian Bjørn⁸ (AUTHOR), Dessau-Arp, Andriette⁹ (AUTHOR), El-Galaly, Tarec Christoffer^1,6,10,11 (AUTHOR), Jakobsen, Lasse Hjort^1,12 (AUTHOR)

Source: Leukemia & Lymphoma. Dec2024, Vol. 65 Issue 14, p2173-2181. 9p.

Subject Terms: *DIFFUSE large B-cell lymphomas, *DRUG efficacy, *OVERALL survival, *ANTINEOPLASTIC combined chemotherapy protocols, *CLINICAL trials

The Impact of Trial Eligibility Criteria on Outcomes in a Nationwide Cohort of Newly Diagnosed DLBCL Patients Treated with R-CHOP

Authors: Severinsen, Freja Tang, Haunstrup, Laura Mors, Jensen, Rasmus Kuhr, Maurer, Matthew J., Khurana, Arushi, Jensen, Paw, Jørgensen, Judit M., Larsen, Thomas Stauffer, Clausen, Michael Roost, Poulsen, Christian Bjørn, Brown, Peter de Nully, El-Galaly, Tarec Christoffer, Jakobsen, Lasse H.

Source: In Blood 23 November 2021 138 Supplement 1:53-53